Kura Oncology
(KURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,466 | -97,723 | -64,357 | -30,694 | -89,625 |
| Depreciation Amortization | 4,949 | 3,567 | 2,219 | 958 | 604 |
| Other Working Capital | -3,224 | -4,822 | -6,132 | -3,856 | 6,384 |
| Other Operating Activity | 24,190 | 17,793 | 11,679 | 5,075 | 12,807 |
| Operating Cash Flow | $-104,551 | $-81,185 | $-56,591 | $-28,517 | $-69,830 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -125,688 | -199,851 | -223,119 | -186,189 | -97,765 |
| PPE Investments | -1,147 | -1,045 | -322 | -31 | -2,171 |
| Investing Cash Flow | $-126,835 | $-200,896 | $-223,441 | $-186,220 | $-99,936 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,250 | -7,250 | -7,250 | -750 | -250 |
| Common Stock Issued | 4,426 | 3,632 | 1,374 | 829 | 469,584 |
| Other Financing Activity | -611 | -611 | -611 | 0 | 0 |
| Financing Cash Flow | $-3,435 | $-4,229 | $-6,487 | $79 | $469,334 |
| Beginning Cash Position | 325,493 | 325,703 | 325,703 | 325,703 | 26,135 |
| End Cash Position | 90,672 | 39,393 | 39,184 | 111,045 | 325,703 |
| Net Cash Flow | $-234,821 | $-286,310 | $-286,519 | $-214,658 | $299,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | -104,551 | -81,185 | -56,591 | -28,517 | -69,830 |
| Capital Expenditure | -1,147 | -1,045 | -322 | -31 | -2,171 |
| Free Cash Flow | -105,698 | -82,230 | -56,913 | -28,548 | -72,001 |